PharmaShots | Incisive News in 3 Shots

Subscribe Now

Phase 2b

Biogen and UCB Reports Results of Dapirolizumab Pegol (DZP) in A P-IIb study for Systemic Lupus Erythematosus (SLE)

Biogen and UCB Reports Results of Dapirolizumab Pegol (DZP) in A P-IIb study for Systemic Lupus Erythematosus (SLE)

October 23, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us